Novartis Investigative Site

Ohtsu, Shiga 5202192

2 studies enrolling now · 4 studies all time

What they study most

C3 Glomerulopathy, C3G, Chronic Inducible Urticaria, Immune-complex-membranoproliferative Glomerulonephritis, Primary Immunoglobulin A Nephropathy (IgAN)

Studies at this site

• Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN — Recruiting now
• Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy. — Recruiting now
• Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Iptacopan in Pediatric Patients With Primary IgAN — Recruiting now
• A Study to Investigate Efficacy, Safety, and Tolerability of Remibrutinib Compared With Placebo in Adults With CINDU Inadequately Controlled by H1-antihistamines — Running, not enrolling